Concepedia

Hans Furuland

HF

Statistics

Publications

20

Citations

1.3K

H-Index

15

Active since

2001

Affiliations

Uppsala University Hospital(Current)

University College London

Karolinska Institutet

Karolinska University Hospital

Health Economics and Outcomes Research (United Kingdom)

Hans Furuland is an author at Uppsala University Hospital specializing in medicine, chronic kidney disease, and renal disease.

ORCID

Publications per year

2001–2022

20

Publications

20

A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients

Hans Furuland · Nephrology Dialysis Transplantation · 2003 · 226 citations · Full text

, , +11

Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial

Hiddo J.L. Heerspink, Bergur V. Stefánsson, Glenn M. Chertow et al. · Nephrology Dialysis Transplantation · 2019 · 216 citations · Full text

, , +17

The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics

David C. Wheeler, Bergur V. Stefánsson, Oleksandr Bilchenko et al. · Nephrology Dialysis Transplantation · 2020 · 190 citations · Full text

, , +17

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs et al. · European Heart Journal · 2021 · 122 citations · Full text

, , +15

Real‐World Associations of Renin–Angiotensin–Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New‐Onset Chronic Kidney Disease or Heart Failure in the United Kingdom

Cecilia Linde, Ameet Bakhai, Hans Furuland et al. · Journal of the American Heart Association · 2019 · 117 citations · Full text

, , +17

1–5 of 20